ArticleComparative biochemistry and physiology. Toxicology & pharmacology : CBP2026
Low-level tetrabromobisphenol A (TBBPA) exposure disrupts early embryonic architecture: molecular impacts on dorsoventral patterning.
Article in Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Tetrabromobisphenol A (TBBPA), a widely used flame retardant in textiles and electronics, poses toxicological risks through both environmental and indoor exposures. Biomonitoring studies have detected significant TBBPA levels in prenatal environments, including cord blood, raising concerns about developmental impacts. Using zebrafish as a model, this study addresses critical gaps in understanding how developmental TBBPA exposures perturb regulatory pathways that govern dorsoventral patterning. Embryos were exposed at 0.75- or 6-h post-fertilization (hpf) and phenotyped at 24 hpf, with tissue uptake quantified by LC-MS. At 24 hpf, embryos exhibited concentration-dependent ventralization characterized by loss of dorsal structures. Whole-mount immunohistochemistry revealed concentration-dependent alterations in dorsoventral, cell adhesion, and germ layer markers, indicating disruptions in cell migration and germ layer integrity. At later stages, even nontoxic exposures led to craniofacial and hematopoietic defects, linking early molecular perturbations to downstream developmental abnormalities. Although the phenotypes strongly resembled BMP pathway overactivation, co-exposure with the BMP inhibitor dorsomorphin failed to rescue the defects, suggesting involvement of alternative mechanisms. Collectively, these findings demonstrate that TBBPA disrupts proteins critical for cell migration, fate specification, and germ layer formation at environmentally relevant concentrations, fundamentally altering embryonic physiology prior to organogenesis and inducing systemic changes in tissue development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.